Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
468 |
|
Actual shortage: | 53 (11%) | |
Anticipated shortage: | 18 (4%) | |
Avoided shortage: | 9 (2%) | |
Resolved: | 388 (83%) | |
Discontinuation Reports |
68 |
|
To be discontinued: | 7 (10%) | |
Discontinued: | 51 (75%) | |
Reversed: | 10 (15%) | |
Late reports |
52 (10%) |
|
Overdue reports |
13 (17%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
LEVETIRACETAM | 500MG | TABLET | Resolved | 2017-10-31 | 2017-11-10 | 27549 |
ROPINIROLE | 0.25MG | TABLET | Resolved | 2017-11-21 | 2017-12-16 | 29895 |
FINASTERIDE | 1MG | TABLET | Resolved | 2017-11-22 | 2018-01-16 | 30104 |
FINASTERIDE | 5MG | TABLET | Avoided shortage | 2017-11-22 | 2018-01-29 | 30107 |
GABAPENTIN | 400MG | CAPSULE | Resolved | 2017-11-22 | 2017-12-22 | 30110 |
OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-11-27 | 2018-12-11 | 30725 |
LEVETIRACETAM | 750MG | TABLET | Resolved | 2017-11-28 | 2017-12-16 | 30910 |
OXYBUTYNIN | 5MG | TABLET | Resolved | 2017-11-28 | 2019-02-06 | 30915 |
PROPAFENONE | 300MG | TABLET | Resolved | 2017-12-12 | 2018-03-08 | 32539 |
GABAPENTIN | 100MG | CAPSULE | Resolved | 2017-12-15 | 2017-12-22 | 33110 |
OXYBUTYNIN | 5MG | TABLET | Resolved | 2017-12-18 | 2019-02-06 | 33667 |
CITALOPRAM | 10MG | TABLET | Resolved | 2017-12-19 | 2018-01-18 | 33689 |
VALACYCLOVIR | 500MG | TABLET | Resolved | 2018-02-08 | 2018-02-22 | 39080 |
LEVETIRACETAM | 250MG | TABLET | Resolved | 2018-02-21 | 2018-03-09 | 40452 |
MONTELUKAST | 5MG | TABLET (CHEWABLE) | Resolved | 2018-02-21 | 2018-03-14 | 40467 |
ACEBUTOLOL | 200MG | TABLET | Resolved | 2018-02-26 | 2019-01-22 | 41071 |
ACEBUTOLOL | 100MG | TABLET | Resolved | 2018-02-26 | 2019-01-22 | 41074 |
IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Resolved | 2018-03-07 | 2018-04-13 | 42112 |
TERAZOSIN | 1MG | TABLET | Resolved | 2018-03-13 | 2018-04-12 | 42542 |
ENALAPRIL | 16MG | TABLET | Resolved | 2018-03-13 | 2018-05-23 | 42549 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TERAZOSIN | 5MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151284 |
LORAZEPAM | 2.0MG | TABLET | Discontinued | 2021-12-16 | 2021-12-17 | 151293 |
BUPROPION SR | 100MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151302 |
BUPROPION SR | 150MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151307 |
SOLIFENACIN | 5MG | TABLET | Discontinued | 2023-09-26 | 2023-09-26 | 205215 |
DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | To be discontinued | 2024-02-15 | 2024-02-15 | 219591 |
DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Reversed | 2024-02-15 | 2024-04-23 | 219618 |
RISEDRONATE | 35MG | TABLET | Discontinued | 2024-02-28 | 2024-02-29 | 220861 |